JOURNAL ARTICLE

Researcher at IIAIGC Study Center Zeroes in on Osteosarcomas (The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive).

  • Published In: Mental Health Weekly Digest, 2023. P. 1435 1 of 2

  • Database: Psychology Source 2 of 2

Abstract

Keywords: Cancer; Drugs and Therapies; Health and Medicine; Oncology; Osteosarcomas EN Cancer Drugs and Therapies Health and Medicine Oncology Osteosarcomas 1435 1435 1 11/06/23 20231106 NES 231106 2023 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- New research on osteosarcomas is the subject of a new report. The nine drugs in OSR9 are: (1) the antinausea drug aprepitant, (2) the analgesic drug celecoxib, (3) the anti-malaria drug chloroquine, (4) the antibiotic dapsone, (5) the alcoholism treatment drug disulfiram, (6) the antifungal drug itraconazole, (7) the diabetes treatment drug linagliptin, (8) the hypertension drug propranolol, and (9) the psychiatric drug quetiapine. [Extracted from the article]

Additional Information

  • Source:Mental Health Weekly Digest. 2023/11, p1435
  • Document Type:Article
  • Subject Area:Health and Medicine
  • Publication Date:2023
  • ISSN:1543-6616
  • Accession Number:173409963
  • Copyright Statement:Copyright of Mental Health Weekly Digest is the property of NewsRx and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.